News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Continue Reading Previous Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories EHR Healthcare News Patient Care Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024 Staff November 22, 2024 News Pharmaceutical Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) Staff November 22, 2024 Clinical Trial News Pharmaceutical Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting Staff November 22, 2024
